The Applied Technical Services Family of Companies (ATS FoC) provides forced degradation testing to evaluate the chemical stability of pharmaceutical drug substances and products under controlled stress conditions. Forced degradation, also called stress testing, exposes a product or active pharmaceutical ingredient to conditions that accelerate degradation. This approach helps identify degradation products, establish degradation pathways, evaluate intrinsic stability, and demonstrate the stability-indicating capability of analytical methods. Our laboratory offers comprehensive forced degradation studies designed to generate scientifically useful data for pharmaceutical development, formulation optimization, analytical method development, and regulatory documentation.
What Role Does Forced Degradation Testing Play in Pharmaceutical Stability Studies?
Forced degradation testing supports pharmaceutical stability programs by revealing how a drug substance or product responds to environmental and chemical stresses before and during formal stability studies. Researchers use these results to understand degradation mechanisms and identify conditions that may affect product quality, safety, or efficacy. ICH Q1A(R2) identifies stress testing as a way to establish degradation pathways, understand intrinsic stability, and evaluate stability-indicating analytical procedures. Our studies can help pharmaceutical developers:
- Identify and characterize degradation products
- Evaluate hydrolytic, oxidative, thermal, and photolytic degradation
- Establish potential degradation pathways
- Support stability-indicating analytical methods
- Investigate formulation and stability concerns
- Generate data for formulation and packaging decisions
About Our Forced Degradation Testing
Our forced degradation testing services provide controlled studies tailored to the drug substance or product characteristics and development program objectives. Our laboratory can evaluate a broad range of pharmaceutical materials, including:
- Drug substances and active pharmaceutical ingredients (APIs)
- Finished pharmaceutical products
- Pharmaceutical formulations
- Solid oral dosage forms, including tablets and capsules
- Liquid formulations, including solutions and suspensions
- Injectable and parenteral products
- Pharmaceutical intermediates
- Excipients and formulation components
Testing may include chemical, thermal, humidity, and light-based stress conditions to produce meaningful degradation profiles. Capabilities include acid, base, oxidative, dry and wet heat, photolytic stress, and accelerated stability conditions with elevated temperature and humidity. Our scientists evaluate samples using appropriate analytical techniques to assess degradation and differentiate degradation products from the pharmaceutical product and formulation components. We also support investigations of material compatibility, degradation mechanisms, formulation stability, and analytical method development. We tailor study design, stress conditions, exposure durations, and analytical approaches to the characteristics and intended use of the tested material.
How Does Forced Degradation Testing Support ICH Stability Requirements?
Forced degradation testing provides scientific information supporting the broader stability strategy described by ICH guidelines. ICH Q1A(R2) identifies temperature, humidity, oxidation, photolysis, and hydrolysis as relevant stress factors depending on the drug substance and product. By generating controlled degradation profiles, our laboratory helps clients understand potential degradation behavior and develop analytical procedures that detect meaningful changes during stability studies. These results support pharmaceutical development and regulatory submissions while helping establish appropriate formulation, packaging, storage, and shelf-life strategies.
Request a Quote
Call +1 (888) 287-5227 or complete a web form to discuss your forced degradation testing requirements and develop a study suited to your pharmaceutical development program.
